Results: 36

    Executive summary of the KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease: Known knowns and known unknowns

    Kidney int; 105 (4), 2024
    Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...

    Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

    Kidney int; 102 (5), 2022
    The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...

    Recommendations for the diagnosis and management of Fabry disease in pediatric patients: a document from the Rare Diseases Committee of the Brazilian Society of Nephrology (Comdora-SBN)

    J. bras. nefrol; 44 (2), 2022
    Fabry disease (FD) is a genetic disease, with X-chromosome linked inheritance, due to variants in the GLA gene that encodes the α-galactosidase A (α-GAL) enzyme. The purpose of the present study was to create a consensus aiming to standardize the recommendations regarding the renal involvement of FD wi...

    Guía de práctica clínica enfermedad renal crónica estadios 1 al 3A para la atención de la población mayor de 18 años en establecimientos de salud del primer nivel de atención

    El presente trabajo se ha enfocado en documentar la variabilidad de la práctica clínica, analizar sus causas y proponer estrategias orientadas a mejorarla; esto fomenta la toma de decisiones efectivas y seguras, centradas en los pacientes, por parte de los profesionales de la salud. Entre dichas estrat...

    Chronic kidney disease: assessment and management: Last updated 24 November 2021

    This guideline covers care and treatment for people with, or at risk of, chronic kidney disease (CKD). It aims to prevent or delay the progression, and reduce the risk of complications and cardiovascular disease. It also covers managing anaemia and hyperphosphataemia associated with CKD. NICE has produce...

    Guía de práctica clínica para el manejo de la enfermedad renal crónica estadios 3B, 4 y 5

    La enfermedad renal crónica (ERC) es una enfermedad de etiología multifactorial caracterizada por el deterioro progresivo de la tasa de filtración glomerular (TFG) en cinco estadios (1). Los estadios 3b, 4 y 5 se caracterizan por una reducción de la TFG que va desde por debajo de 45 ml/min/1.73m2 has...

    Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

    Kidney int; 99 (3), 2021
    The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease for patients not receiving dialysis represents an update to the KDIGO 2012 guideline on this topic. Development of this guideline update followed a rigorou...

    COVID-19 rapid guideline: chronic kidney disease

    The purpose of this guideline is to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....